Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 625Stomach Neoplasms 75Neoplasm Metastasis 59Neoplasms 39HER2-positive Breast Cancer 33Breast Neoplasms, Male 30Colorectal Neoplasms 28Brain Neoplasms 25Carcinoma, Non-Small-Cell Lung 21Inflammatory Breast Neoplasms 20Esophageal Neoplasms 20Pancreatic Neoplasms 13Triple Negative Breast Neoplasms 12Lung Neoplasms 11Endometrial Neoplasms 11Ovarian Neoplasms 10Colonic Neoplasms 10Urinary Bladder Neoplasms 9Rectal Neoplasms 9Prostatic Neoplasms 9Cardiotoxicity 8Adenocarcinoma 8Salivary Gland Neoplasms 7Gallbladder Neoplasms 7Breast Diseases 7Biliary Tract Neoplasms 7Adenocarcinoma Of Esophagus 7Uterine Cervical Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6

Interventions

Blood Specimen Collection 29Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Surgical Procedures, Operative 4Liquid Biopsy 4cabazitaxel 3Trastuzumab 3Propofol 3Carboplatin 3Bevacizumab 3Standard of Care 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Neoadjuvant Therapy 2Morphine 2Laparoscopy 2Hematologic Tests 2Gemcitabine 2Folfox protocol 2Epirubicin 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Capecitabine 2Aspirin 2Anesthesia, General 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × Trastuzumab × Clear all
NCT04168931 2023-01-17

GASTHER2

AC Camargo Cancer Center

Phase 2 Terminated
5 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Stomach Neoplasms

NCT04993014 2021-08-06

HER2Cell

AC Camargo Cancer Center

Phase 2 Recruiting
80 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT01548677 2019-03-13

TREAT-CTC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
1,317 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡